News China Isotope & Radiation Corporation

Stocks

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. 23:37:59 2026-09-20 EDT			5-day change	1st Jan Change
13.85 ^HKD	-3.82%		+2.67%	-31.44%

08-28	China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 27 November 2026	CI

All News

Mentions Relevance

08-28	China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 27 November 2026	CI
08-28	China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026	CI
08-28	China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026	CI
07-05	China Isotope to Form JV With Associate	MT
07-03	China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan	CI
06-18	China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026	CI
06-18	China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board	CI
05-26	China Isotope Proposes Auditor Change	MT
05-26	China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026	CI
03-27	China Isotope & Radiation final cash dividend of RMB0.2264 per share	RE
03-27	China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026	CI
03-27	China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-19	China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection	RE
03-13	China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement	CI
03-13	China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality	RE
03-02	China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer	MT
02-12	China Isotope & Radiation Warns of Up to 25% Lower 2025 Profit	MT
02-12	China Isotope & Radiation Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025	CI
12-19	China Isotope & Radiation says Zhonghe Headway obtained clinical trial approval for BNCT boron drug	RE
12-19	China Isotope & Radiation's Unit Gets China Nod for Trial of Tumor Drug	MT
12-15	China Isotope & Radiation says unit entered commercial cooperation agreement with Novartis	RE
12-11	China Isotope & Radiation Renews Contracts With CNNC	MT
11-27	China Isotope & Radiation Corp says co, CNNC Capital enter strategic cooperation deal	RE
11-26	China Isotope Partners With CNNC Capital on M&A and Investment Cooperation	MT